{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:00:36Z","timestamp":1794373236551,"version":"4.9.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","aaojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ophtha.2024.04.022","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T01:24:53Z","timestamp":1714699493000},"page":"1215-1224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Intravitreal Topotecan for Vitreous Seeds in\u00a0Retinoblastoma"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0042-5132","authenticated-orcid":false,"given":"Mrittika","family":"Sen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raksha","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaustubh","family":"Mulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay Anand P.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1050-773X","authenticated-orcid":false,"given":"Santosh G.","family":"Honavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ophtha.2024.04.022_bib1","first-page":"1548","article-title":"Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre","volume":"104","author":"Shields","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ophtha.2024.04.022_bib2","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archophthalmol.2011.150","article-title":"Intra-arterial chemotherapy for retinoblastoma: report no. 1, control of retinal tumors, subretinal seeds, and vitreous seeds","volume":"129","author":"Shields","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2024.04.022_bib3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/eye.2012.175","article-title":"Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy","volume":"27","author":"Shields","year":"2013","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.ophtha.2024.04.022_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/bjophthalmol-2011-300498","article-title":"Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and\/or subretinal seeding: 2-year results","volume":"96","author":"Abramson","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2024.04.022_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1755-3768.1961.tb00269.x","article-title":"Present therapeutic resources in retinoblastoma","volume":"39","author":"Ericson","year":"1961","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2024.04.022_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/13816810.2014.973045","article-title":"Classification and management of seeds in retinoblastoma. Ellsworth Lecture Ghent August 24th, 2013","volume":"35","author":"Munier","year":"2014","journal-title":"Ophthalmic Genet"},{"issue":"2","key":"10.1016\/j.ophtha.2024.04.022_bib7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/bjo.79.2.194","article-title":"Intravitreal chemotherapy for recurrent retinoblastoma in an only eye","volume":"79","author":"Seregard","year":"1995","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ophtha.2024.04.022_bib8","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.ophtha.2011.02.005","article-title":"Intravitreal methotrexate for retinoblastoma","volume":"118","author":"Kivel\u00e4","year":"2011","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ophtha.2024.04.022_bib9","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/bjophthalmol-2011-301016","article-title":"Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2024.04.022_bib10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/bjophthalmol-2017-310641","article-title":"Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma","volume":"102","author":"Rao","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2024.04.022_bib11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/bjophthalmol-2018-312037","article-title":"Intravitreal chemotherapy in retinoblastoma: expanded use beyond intravitreal seeds","volume":"103","author":"Abramson","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2024.04.022_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0002-9394(02)01348-X","article-title":"Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation","volume":"133","author":"Shields","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ophtha.2024.04.022_bib13","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.ophtha.2017.05.034","article-title":"Not all seeds are created equal: seed classification is predictive of outcomes in retinoblastoma","volume":"124","author":"Berry","year":"2017","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ophtha.2024.04.022_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000491580","article-title":"Primary intra-arterial chemotherapy for retinoblastoma in the intravitreal chemotherapy era: five years of experience","volume":"5","author":"Dalvin","year":"2019","journal-title":"Ocular Oncol Pathol"},{"issue":"8","key":"10.1016\/j.ophtha.2024.04.022_bib15","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bjophthalmol-2011-301450","article-title":"Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2024.04.022_bib16","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.ophtha.2015.01.017","article-title":"The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan","volume":"122","author":"Francis","year":"2015","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ophtha.2024.04.022_bib17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamaophthalmol.2013.7666","article-title":"Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results","volume":"132","author":"Shields","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2024.04.022_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/0301-4738.154390","article-title":"The role of intravitreal chemotherapy for retinoblastoma","volume":"63","author":"Manjandavida","year":"2015","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2024.04.022_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1076\/opge.25.1.37.28996","article-title":"Activity of topotecan in retinoblastoma","volume":"25","author":"Chantada","year":"2004","journal-title":"Ophthalmic Genet"},{"issue":"6","key":"10.1016\/j.ophtha.2024.04.022_bib20","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archophthalmol.2011.130","article-title":"Periocular topotecan for intraocular retinoblastoma","volume":"129","author":"Mallipatna","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.ophtha.2024.04.022_bib21","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jamaophthalmol.2014.414","article-title":"Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma","volume":"132","author":"Ghassemi","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"10.1016\/j.ophtha.2024.04.022_bib22","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/bjophthalmol-2020-316588","article-title":"Is intravitreal topotecan toxic to retinal function?","volume":"105","author":"Nadelmann","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2024.04.022_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.822330","article-title":"Treatment of retinoblastoma: what is the latest and what is the future","volume":"12","author":"Schaiquevich","year":"2022","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ophtha.2024.04.022_bib24","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/archopht.120.4.460","article-title":"Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma","volume":"120","author":"Shields","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2024.04.022_bib25","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archophthalmol.2012.1983","article-title":"Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma","volume":"130","author":"Ghassemi","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2024.04.022_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00043426-199807000-00006","article-title":"Topotecan in pediatric patients with recurrent and progressive solid tumors: a Pediatric Oncology Group phase II study","volume":"20","author":"Nitschke","year":"1998","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"2","key":"10.1016\/j.ophtha.2024.04.022_bib27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/cncr.25574","article-title":"Subconjunctival carboplatin and systemic topotecan treatment in preclinical models of retinoblastoma","volume":"117","author":"Nemeth","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ophtha.2024.04.022_bib28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/bjophthalmol-2020-318529","article-title":"Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study","volume":"106","author":"Bogan","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2024.04.022_bib29","first-page":"e16","article-title":"Intravitreal topotecan 90 \u03bcg for recurrent solid retinoblastoma tumors is effective and not toxic","volume":"60","author":"Abramson","year":"2023","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"},{"issue":"4","key":"10.1016\/j.ophtha.2024.04.022_bib30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.5301\/ejo.5000921","article-title":"Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma","volume":"27","author":"Kiratli","year":"2017","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2024.04.022_bib31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000486098","article-title":"Integrated treatment during the intravitreal melphalan era: concurrent intravitreal melphalan and systemic chemoreduction","volume":"4","author":"Berry","year":"2018","journal-title":"Ocular Oncol Pathol"},{"issue":"1","key":"10.1016\/j.ophtha.2024.04.022_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146582","article-title":"Intra-arterial chemotherapy (ophthalmic artery chemosurgery) for group D retinoblastoma","volume":"11","author":"Abramson","year":"2016","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.ophtha.2024.04.022_bib33","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1097\/IAE.0b013e318295f783","article-title":"Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation","volume":"33","author":"Shields","year":"2013","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.ophtha.2024.04.022_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26696","article-title":"Long-term outcomes of group D retinoblastoma eyes during the intravitreal melphalan era","volume":"64","author":"Berry","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.ophtha.2024.04.022_bib35","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/IAE.0000000000000903","article-title":"Intravitreous chemotherapy for active vitreous seeding from retinoblastoma","volume":"36","author":"Shields","year":"2016","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.ophtha.2024.04.022_bib36","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s10384-015-0378-0","article-title":"Intravitreal injection of melphalan for intraocular retinoblastoma","volume":"59","author":"Suzuki","year":"2015","journal-title":"Jpn J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2024.04.022_bib37","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.ophtha.2017.04.015","article-title":"Vitreous seeds in retinoblastoma: clinicopathologic classification and correlation","volume":"124","author":"Amram","year":"2017","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ophtha.2024.04.022_bib38","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1136\/bjophthalmol-2013-303188","article-title":"Evaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: a systematic review","volume":"97","author":"Smith","year":"2013","journal-title":"Br J Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642024002768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642024002768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T08:13:07Z","timestamp":1728547987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642024002768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0161642024002768"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2024.04.022","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal Topotecan for Vitreous Seeds in\u00a0Retinoblastoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2024.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}